Statement on Registration Statement on Form S-1 filed by Harvard Apparatus Regenerative Technology, Inc.

On December 11, 2012, Harvard Bioscience, Inc. (the "Company") issued a press release announcing that its wholly-owned subsidiary, Harvard Apparatus Regenerative Technology, Inc., filed a registration statement with the SEC for an initial public offering of its common stock. The press release is furnished as Exhibit 99.1 and incorporated herein by reference.

Such registration statement on Form S-1 relating to common stock of Harvard Apparatus Regenerative Technology, Inc. has been filed with the SEC but has not yet become effective. The common stock subject to such registration statement may not be sold nor may offers to buy these securities be accepted before the time the registration statement becomes effective. This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

(d) Exhibits.

Exhibit
Number   Title

99.1     Press Release issued on December 11, 2012.